Genotype-guided diagnostic reassessment after exome sequencing in neuromuscular disorders: experiences with a two-step approach.
Martin KrennMatthias TomschikJ RathH CetinA GrisoldG ZulehnerIvan MilenkovicE StogmannA ZimprichT M StromT MeitingerMatias WagnerF ZimprichPublished in: European journal of neurology (2019)
Exome sequencing allows the detection of pathogenic variants missed by (narrowly) targeted gene panel approaches. Diagnostic reassessment after genetic testing further enhances the diagnostic outcomes for NMDs.